Solution formulation for continuous flow peritoneal dialysis

Contributions to Nephrology

Volumn 140, Issue , 2003, Pages 309-317

  Diaz Buxo, José A ^a,b  

^a FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^b Home Dialysis Therapies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21244495513     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000071404     Document Type: Article

References (40)

1. Diaz-Buxo JA: Evolution of continuous flow peritoneal dialysis and the current state of the art. Semin Dial 2001;14:373-377.
2. Jörres A, Gahl GM, Frei U: Peritoneal dialysis biocompatibility: Does it really matter? Kidney Int 1994;48:S79-S86.
3. Duwe AK, Vas SI, Weatherhead JW: Effects of the composition of peritoneal dialysis fluid on chemoluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981;33: 130-135.
4. Passlick-Deetjen J, Schuab TP, Schilling H: Solutions for APD: Special considerations. Semin Dial 2002; 15:407-413.
5. Douvdevani A, Rapoport J, Konforty A, Yulzari R, Moran A, Chamovitz C: Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 1995;6:207-213.
6. Liberek T, Topley N, Jorres A, Petersen MM, Coles GA, Gahl GM, Williams JD: Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993;65:260-265.
7. Alscher DM, Pauli-Magnus C, Kirchgessner U, Mettang T: A new lactate-based plasticizer-free peritoneal dialysis fluid in a two-compartment system: Effect of peripheral leukocyte function. Nephron 2000;86:62-69.
8. Wieslander A, Forsbäck G, Svensson E, Lindén T: Cytotoxicity pH and glucose degradation products in four different brands of PD fluid. Adv Perit Dial 1996; 15:57-60.
9. Wieslander AP, Deppisch R, Svensson E, Forsbäck G, Speidel R, Rippe B: In vitro biocompatibility of a heat-sterilized, low-toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995;15:158-164.
10. Passlick-Deetjen J, Pischetsrieder M, Witowski J, Bender TO, Jörres A, Lage C: In vitro superiority of dual-chambered peritoneal dialysis solution with possible clinical benefits. Périt Dial Int 2001; 21(suppl 3):96-101.
11. Lage C, Pischetsrieder M, Aufricht C, Jorres A, Schilling H, Passlick-Deetjen J: First in vitro and in vivo experiences with stay-safe balance, a pH-neutral solution in a dual-chambered bag. Perit Dial Int 2000;20(suppl 5):28-32.
12. Friedrichsohn C, Schilling H, Topp G, Passlick-Deetjen J, Riegel W: Führt die CAPD-stay-safeBalance-Lösung zu einer Erhöhung der Mesothelzellmasse? (Abstract) Nieren Hochdruckkr 2000;8:360.
13. Haas S, Schmitt CP, Schaub T, Schaefer F: Use of pH-neutral, bicarbonate buffered PD fluids in children on APD: Results of a randomized cross-over trial (abstract). Perit Dial Int 2002; 22(suppl 1):71.
14. Craig KJ, Mackenzie RM, Lage C, Craig KJ, Williams JD, Schaub T, Passlick-Deetjen J, Topley N: Treatment with low GDP solution (balance) is associated with an increase in effluent CA125 and a decrease in HA content: Data from the multi-centre Euro Balance Trial. Perit Dial Int 2002; 22(suppl 2):21.
15. Mortier S, De riese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration and glucose degradation products. J Am Soc Nephrol 2002; 13:480-489.
16. Cruz C, Melendez A, Gotch FA, Folden T, Crawford T, Diaz-Buxo JA: Single-pass continuous flow peritoneal dialysis using two catheters. Semin Dial 2001;14:391-394.
17. Raj DS, Self M, Work J: Hybrid dialysis: Recirculation peritoneal dialysis revisited. Am J Kidney Dis 2000;36:58-67.
18. Mineshima S, Suzuki Y, Sato I, Ishimori K, Ishida I, Kaneko I, Agishi T: Solute removal characteristics of continuous recirculating peritoneal dialysis in experimental and clinical studies. ASAIO J 2000;46:95-98.
19. Passlick-Deetjen J, Quellhorst E: Continuous flow peritoneal dialysis: A glimpse into the future. Nephrol Dial Transplant 2001;16:2296-2299.
20. Diaz-Buxo JA: Streaming, mixing and recirculation: Role of the peritoneal access in CFPD. Adv Perit Dial 2002; 18:87-90.
21. Shen FH, Sherrard DJ, Scollard D, Merritt A, Curtis FK: Thirst, relative hypernatremia and excessive weight gain in maintenance peritoneal dialysis. Trans Am Soc Artif Intern Organs 1978; 24:142-149.
22. Imholz ALT, Koomen GCM, Struijk DG, Arisz L, Krediet RT: Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 1994;46:333-340.
23. Leypoldt JK, Charney DI, Cheung AK, Naprestek CL, Akin BH, Shockley TR: Ultrafiltration and solute kinetics using low sodium peritoneal dialysate. Kidney Int 1996;48:1959-1966.
24. Nakayama N, Kawaguchi Y, Yokoyama K, Kubo H, Miura Y, Watanabe S, Sakai O: Antihypertensive effect of a low sodium concentration (120mmol/1) solution for CAPD patients. Clin Nephrol 1996;41:188-193.
25. 3 solution with low sodium concentration over standard lactate solutions for acute peritoneal dialysis. Adv Perit Dial 1997;13:179-182.
26. Ortega O, Gallar P, Carreno A, Guiterrez M, Rodriguez I, Oliet A, Vigil A, Gimenez E: Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: Influence on blood pressure control. Am J Nephrol 2001;21:189-193.
27. Weinreich T, Colombi A, Echterhoff HH, Mielke G, Nebel M, Ziegelmayer C, Passlick-Deetjen J: Transperitoneal calcium mass transfer using dialysate with a low calcium concentration (1.0 mM). Perit Dial Int 1993;13(suppl 2):467-470.
28. Montenegro J, Saracho R, Aquirre R, Martinez I: Calcium mass transfer in CAPD: The role of convective transport. Nephrol Dial Transplant 1993;8:1234-1236.
29. Hutchinson A, Merchant M, Boulton HF, Hinchcliffe R, Gokal R: Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25mmol/1 calcium and 0.25mmol/1 magnesium dialysis fluid. Perit Dial Int 1993;13:219-223.
30. Ritz E, Passlick-Deetjen J, Zeier M, Stefanski A: Prescription of calcium concentration and PTH control. Perit Dial Int 1996;16(suppl 1):300-304.
31. Ritz E, Passlick-Deetjen J, Lippert J: What is the appropriate dialysate calcium concentration for the dialysis patient? Nephrol Dial Transplant 1996; 11:91-95.
32. Brandi L, Nielsen PK, Bro K, Daugaard H, Olgaard K: Long-term effects of intermittent oral α-calcidiol, calcium carbonate and low-calcium dialysate (1.25mmol/l) on secondary hyperparathyroidism in patients on CAPD. J Intern Med 1998;244:121-131.
33. Hutchinson A, Gokal R: Calcium content in automated peritoneal dialysis solutions. Contrib Nephrol. Basel, Karger, 1999, vol 129, pp 168-176.
34. Malberti F, Corradi B, Imbasciati E: Calcium mass transfer and kinetics in CAPD using calciumfree solutions. Adv Perit Dial 1993;9:274-279.
35. Feriani M: Bicarbonate-buffered CAPD solutions: From clinical trials to clinical practice. Perit Dial Int 1997;17(suppl l):51-55.
36. Feriani M, Carobi C, La Greca G, Buoncristiani U, Passlick-Deetjen J: Clinical experience with a 39mmol/l bicarbonate-buffered peritoneal dialysis solution. Perit Dial Int 1997;17:17-21.
37. Feriani M, Kirchgessner J, La Greca G, Passlick-Deetjen J: Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 1998;54:1731-1738.
38. Schmitt CP, Haraldsson B, Doetschmann R, Zimmering M, Greiner C, Böswald M, Klaus G, Passlick-Deetjen J, Schaefer F: Effect of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children. Kidney Int 2002;61:1527-1536.
39. Feriani M, La Greca G, Passlick-Deetjen J, Jackle-Meyer J: European multicenter study comparing a 34mmol/1 and a 39mmol/1 bicarbonate-containing solution (abstract). Perit Dial Int 1998;18:123.
40. Diaz-Buxo JA, Cruz C, Gotch FA: Continuous flow peritoneal dialysis: Preliminary results. Blood Purif 2000;18:361-365.